Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,191 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06936670Recruiting
Breathing exercises for heart and kidney health in type 2 diabetes
This study tests if a special breathing exercise program (strengthening your breathing muscles) can improve heart, kidney, and blood vessel health in young people with type 2 diabetes. It is a 12-week home-based program that might help your body work better.
Seattle, WashingtonAges 14–40 - NCT06959030Recruiting
Study of Henagliflozin for Type 2 Diabetes
This study tests how safe and effective the diabetes medication henagliflozin is for Chinese patients with type 2 diabetes. It is an observational study, meaning you will continue your regular care while researchers watch your progress.
Beihai, GuangxiAges 18–80 - NCT06964620RecruitingEarly Phase 1
Sanggua Tablets for prediabetes and mild type 2 diabetes
This trial tests whether Sanggua Tablets, an herbal medicine, can help people with prediabetes or mild type 2 diabetes improve their blood sugar control without needing other medications.
Wuhan, HubeiAges 18–70 - NCT06969391Recruiting
Diet and type 2 diabetes in migrant patients
This study looks at how diet affects type 2 diabetes in people who moved to France. It aims to understand your eating habits and help manage your blood sugar better.
Saint-DenisAges 18 years+ - NCT06981234RecruitingPhase 2
Acetazolamide for type 1 diabetes
This trial tests whether a medicine called acetazolamide (used for altitude sickness) can help people with type 1 diabetes. It compares how your body responds while on the drug versus a placebo, using a crossover design so everyone gets both treatments.
La Jolla, CaliforniaAges 18 years+ - NCT06983054RecruitingPhase 4
Salt, kidneys, and ertugliflozin in type 2 diabetes
This study tests if changing how much salt you eat affects how the drug ertugliflozin works in people with type 2 diabetes. You would take either the drug or a placebo (a dummy pill) for a short time while following a low- or high-salt diet, to see how your kidneys and blood vessels respond.
Denver, ColoradoAges 18–85 - NCT06989723RecruitingPhase 4
Pioglitazone and empagliflozin for fatty liver in type 2 diabetes
This trial tests two diabetes pills (pioglitazone and empagliflozin) to see if they can reduce liver fat in people with type 2 diabetes and fatty liver disease. It may help if your diabetes is not well controlled and you have a fatty liver confirmed by a special ultrasound scan.
Seongnam-siAges 20 years+ - NCT06994403Recruiting
Pasta and blood sugar in type 1 diabetes
This study checks how eating a special carb-enriched pasta affects blood sugar in people with type 1 diabetes and compares it to healthy volunteers. It may help find better mealtime strategies for managing diabetes.
NaplesAges 18–50 - NCT07002125Recruiting
Whole body vibration therapy for type 2 diabetes
This study tests whether whole body vibration therapy can help people with type 2 diabetes manage their blood sugar better. It involves standing on a vibrating platform for short sessions, which may improve muscle function and glucose control without needing exercise.
Ankara, ÇankayaAges 18 years+ - NCT07006272Recruiting
Closed-loop pump vs islet transplant for unstable type 1 diabetes
This study compares two advanced treatments for type 1 diabetes that is hard to control: a closed-loop insulin pump system (which automatically adjusts insulin) versus islet cell transplantation (which replaces the cells that make insulin). It is for people whose blood sugar stays very unstable despite using the best current therapies.
Lyon, Auvergne-Rhône-AlpesAges 18 years+ - NCT07023172Recruiting
Study of Proline Plus Empagliflozin for Type 2 Diabetes
This study is testing a new medication called Proline Plus Empagliflozin to see how well it works for people with type 2 diabetes. It is for people who are starting this medication for the first time.
Xinyang, HenanAges 18 years+ - NCT07042399Recruiting
Self-care study for type 2 diabetes
This study looks at how people with type 2 diabetes take care of themselves. It aims to learn more about their self-care habits so that doctors can better support them.
San Donato Milanese, MilanAges 18 years+ - NCT07051564Recruiting
Cell injection study for type 1 diabetes
This trial tests a new cell injection (CNK-UT009) for adults with type 1 diabetes. The goal is to see if it can help manage blood sugar and reduce insulin needs.
Zibo, ShandongAges 18–65 - NCT07057518Recruiting
Tapping technique for emotional well-being in type 2 diabetes
This study tests a technique called Emotional Freedom Technique (tapping) to see if it can improve your emotional well-being and mental health. If you have type 2 diabetes and are looking for ways to feel better emotionally, this study might be a good fit.
IstanbulAges 18 years+ - NCT07064486RecruitingPhase 3
BGM0504 for type 2 diabetes in Indonesia
This study tests a new medicine called BGM0504 for people with type 2 diabetes who are already taking metformin. It may help improve blood sugar control and weight.
Depok, West JavaAges 18–75 - NCT07065721Recruiting
Continuous glucose monitors for young adults with type 2 diabetes
This trial tests if using a continuous glucose monitor (a small sensor that checks your sugar levels without fingersticks) helps young adults manage type 2 diabetes better. You will wear the sensor and use a phone app to track your glucose.
San Diego, CaliforniaAges 18–45 - NCT07069166Recruiting
Good bacteria mouth rinse for gum disease and diabetes
This study tests whether a mouth rinse containing helpful bacteria (called parabiotics) can improve gum health in people who have both gum disease and type 2 diabetes. It may offer a simple, non-drug way to manage inflammation.
Pavia, LombardyAges 18–70 - NCT07079189Recruiting
Digital lifestyle tool for type 2 diabetes
This trial tests a digital lifestyle tool combined with a smart chatbot to help people with type 2 diabetes improve their blood sugar control. It's a home-based program that gives personalized advice and support.
Malmö, Skåne CountyAges 35 years+ - NCT07082114RecruitingPhase 3
Testing a new tablet for type 2 diabetes
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
Yueyang, HunanAges 18–75 - NCT07083154RecruitingPhase 3
Testing a dual-action drug for diabetes and early memory loss
This study tests if a new type of diabetes drug that targets two natural hormones can help people with type 2 diabetes who also have early memory problems. If you have type 2 diabetes and mild cognitive impairment or mild dementia, this trial may offer a potential treatment option.
Changsha, HunanAges 50–75 - NCT07083336Recruiting
Diet study for type 2 diabetes with fatty liver disease
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
Yichang, HubeiAges 18 years+ - NCT07093476RecruitingPhase 3
Adding empagliflozin to improve blood sugar control
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
SeoulAges 19 years+ - NCT07097805Recruiting
GLITTER: Improving blood sugar with team, tech, and support
This study tests whether a team approach—including technology, education, and support from peers—can help people with type 1 diabetes improve their blood sugar levels. It may be a good fit if you have type 1 diabetes and are looking for extra help managing it.
Beijing, Beijing MunicipalityAges Any age - NCT07120334Recruiting
Mobile health app for stroke survivors with prediabetes or diabetes
This trial tests a mobile app that helps people recovering from a stroke who also have prediabetes or type 2 diabetes improve their diet and health. You will use the app for about 12 weeks, and it may help you manage your blood sugar and prevent future strokes.
Honolulu, HawaiiAges 30–65
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,191 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.